Jun Okada
President presso 3-D MATRIX, LTD.
Patrimonio netto: 169 836 $ in data 31/03/2024
Profilo
Jun Okada is currently the President & Representative Director at 3-D Matrix Ltd.
He is also a Director at 3-D Matrix, Inc., 3-D Matrix Da America Latina Representacão Comercial Ltda., 3-D Matrix Asia Pte.
Ltd., 3-D Matrix Europe SAS, and Beijing 3-D Matrix Investment Consulting, Ltd.
Mr. Okada has an MBA from INSEAD and a graduate degree from the University of Tokyo Faculty of Law & Graduate Schools for Law.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
3-D MATRIX, LTD.
0.26% | 30/04/2023 | 204 000 ( 0.26% ) | 169 836 $ | 31/03/2024 |
Posizioni attive di Jun Okada
| Società | Posizione | Inizio |
|---|---|---|
| 3-D MATRIX, LTD. | President | 01/03/2016 |
| 3-D Matrix Asia Pte. Ltd. | Director/Board Member | 01/10/2012 |
3-D Matrix Da America Latina Representacão Comercial Ltda.
 3-D Matrix Da America Latina Representacão Comercial Ltda. Pharmaceuticals: MajorHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Da America Latina Representacão Comercial Ltda. is a medical product company based in São Paulo, Brazil. The Brazilian company engages in the research and development, manufacture, and sale of medical products. | Director/Board Member | 01/06/2014 |
| Beijing 3-D Matrix Investment Consulting, Ltd. | Director/Board Member | 01/08/2014 |
3-D Matrix Europe SAS
 3-D Matrix Europe SAS Medical SpecialtiesHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Europe SAS is a medical device company based in Lyon, France. The French company specializes in bleeding management in healthcare procedures using self-assembling peptide technology. The private company's products, Purabond and Purastat, provide surgeons with a ready-to-use haemostatic agent in cardiac surgery and endoscopy. The company works with a team of suppliers and distributors to ensure their products reach hospitals. 3-D Matrix is a spin-off from MIT and has grown to become a leading peptide solutions company. | Director/Board Member | 01/04/2012 |
| 3-D Matrix, Inc. | Director/Board Member | 01/04/2016 |
Formazione di Jun Okada
| INSEAD | Masters Business Admin |
| University of Tokyo Faculty of Law & Graduate Schools for Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| 3-D MATRIX, LTD. | Health Technology |
| Aziende private | 5 |
|---|---|
| 3-D Matrix, Inc. | |
3-D Matrix Da America Latina Representacão Comercial Ltda.
3-D Matrix Da America Latina Representacão Comercial Ltda. Pharmaceuticals: MajorHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Da America Latina Representacão Comercial Ltda. is a medical product company based in São Paulo, Brazil. The Brazilian company engages in the research and development, manufacture, and sale of medical products. | Health Technology |
| 3-D Matrix Asia Pte. Ltd. | |
3-D Matrix Europe SAS
3-D Matrix Europe SAS Medical SpecialtiesHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Europe SAS is a medical device company based in Lyon, France. The French company specializes in bleeding management in healthcare procedures using self-assembling peptide technology. The private company's products, Purabond and Purastat, provide surgeons with a ready-to-use haemostatic agent in cardiac surgery and endoscopy. The company works with a team of suppliers and distributors to ensure their products reach hospitals. 3-D Matrix is a spin-off from MIT and has grown to become a leading peptide solutions company. | Health Technology |
| Beijing 3-D Matrix Investment Consulting, Ltd. |
- Borsa valori
- Insiders
- Jun Okada
